Nutrien Ltd.
NYSE:NTRAgricultural Inputs
-$1.56 today
- Market cap
- $31.25B
- Beta
- 1.06
- P/E (TTM)
- 12.6
- EPS (TTM)
- $4.96
- Dividend yield
- 3.48%
Volume 1.80M
Average 3.18M
NTR Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Nutrien Ltd.NYSE: NTR
Cash & Equivalents · Q2 FY2026 · quarter ended Jun 2026
Cash & equivalents falls 33.6% from a year ago
Cash & equivalents stood at $921M at the end of Q2 FY2026, down 33.6% from a year earlier and up 18.1% from the prior quarter. Over 3 fiscal years it compounded at -8.1% a year.
Context
- Cash & equivalents amounted to 1.7% of total assets at the end of Q2 FY2026, down 0.9 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -33.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 699.72M USD
- Year-over-year change
- -18.0%
- 4-year CAGR
- +8.8%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 699.72M | -18.0% |
| FY2024 | 2024-12-31 | 853M | -9.4% |
| FY2023 | 2023-12-31 | 941M | +4.4% |
| FY2022 | 2022-12-31 | 901M | +80.6% |
| FY2021 | 2021-12-31 | 499M | — |
Cash & Equivalents vs competitors
How NTR compares with its peers on the latest reported figures
- NTR's Jun 2026 cash & equivalents of $921M is the 2nd highest of the 4 companies compared; the peer median is $494M.
- Its year-over-year change of -33.6% is the lowest of 4, against a peer median of +47.1%.
- Cash & equivalents amounts to 1.7% of total assets for NTR, versus a peer median of 3.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $2.48B | +47.1% | -5.2% | 16.4% | |
| Jun 2026 | $921M | -33.6% | -8.1% | 1.7% | |
| Sep 2026 | $494M | +38.8% | -11.3% | 3.7% | |
| Sep 2026 | $272.6M | +77.8% | -27.8% | 1.1% | |
| Peer median (excluding NTR) | $494M | +47.1% | -11.3% | 3.7% | |
Competitors are the stored peer set for NTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 499M | 901M | 941M | 853M | 699.72M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 4.71B | 5.6B | 4.67B | 5.39B | 5.66B |
| Inventory | 6.33B | 7.63B | 6.34B | 6.15B | 6.96B |
| Other Current Assets | 661M | 598M | 730M | 0 | 1.39B |
| Total Current Assets | 13.85B | 16.34B | 14.17B | 13.79B | 14.72B |
| Property, Plant & Equipment (Net) | 20.02B | 21.77B | 22.46B | 22.6B | 22.71B |
| Goodwill | 12.22B | 12.37B | 12.11B | 12.04B | 12.11B |
| Intangible Assets | 2.34B | 2.3B | 2.22B | 1.82B | 1.66B |
| Long-term Investments | 703M | 843M | 736M | 698M | 143.74M |
| Tax Assets | 262M | 448M | 477M | 401M | 0 |
| Other Non-current Assets | 567M | 521M | 574M | 483M | 856.44M |
| Total Non-current Assets | 36.11B | 38.24B | 38.58B | 38.05B | 37.48B |
| Total Assets | 49.95B | 54.59B | 52.75B | 51.84B | 52.21B |
| Account Payables | 5.18B | 5.8B | 5.48B | 5.36B | 9.29B |
| Short-term Debt | 2.11B | 2.68B | 2.33B | 2.57B | 1.73B |
| Tax Payables | 606M | 1.07B | 13.93M | 71M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.14B | 3.71B | 2.6B | 2.47B | 0 |
| Total Current Liabilities | 12.44B | 14.28B | 12.12B | 12.05B | 11.02B |
| Long-term Debt | 7.52B | 8.04B | 8.91B | 8.88B | 10.27B |
| Deferred Tax Liabilities | 3.17B | 3.55B | 3.57B | 3.54B | 3.66B |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 2.19B | 1.96B | 1.94B | 1.93B | 1B |
| Total Non-current Liabilities | 13.81B | 14.44B | 15.43B | 15.35B | 15.87B |
| Total Liabilities | 26.26B | 28.72B | 27.55B | 27.4B | 26.89B |
| Common Stock | 15.46B | 14.17B | 13.84B | 13.75B | 13.49B |
| Retained Earnings | 8.19B | 11.93B | 11.53B | 11.11B | 12.05B |
| Accumulated OCI | (146M) | (391M) | (296M) | (515M) | (328.4M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 47M | 45M | 45M | 35M | 41.92M |
| Total Equity | 23.7B | 25.86B | 25.2B | 24.44B | 25.32B |
| Total Debt | 10.85B | 11.93B | 12.57B | 12.81B | 12.93B |
| Net Debt | 10.35B | 11.03B | 11.63B | 11.95B | 12.23B |
Nutrien Ltd.
NYSE:NTR
Intrinsic Alpha fair value
Locked
Current Price
$65.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.